Literature DB >> 4591789

Tumor-associated antigens in human malignant melanoma.

M G Lewis, P J Avis, T M Phillips, K M Sheikh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4591789      PMCID： PMC2591994     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN： 0044-0086


× No keyword cloud information.
  15 in total

1.  A new method of active immunisation to autologous human tumour tissue.

Authors:  P L Wolf; J Vazquez; N P Czajkowski; M Rosenblatt
Journal:  Lancet       Date:  1967-10-28       Impact factor: 79.321

2.  In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma.

Authors:  U W Jehn; L Nathanson; R S Schwartz; M Skinner
Journal:  N Engl J Med       Date:  1970-08-13       Impact factor: 91.245

3.  Demonstration of antibodies against human malignant melanoma by immunofluorescence.

Authors:  D L Morton; R A Malmgren; E C Holmes; A S Ketcham
Journal:  Surgery       Date:  1968-07       Impact factor: 3.982

4.  Possible explanation for loss of detectable antibody in patients with disseminated malignant melanoma.

Authors:  M G Lewis; T M Phillips; K B Cook; J Blake
Journal:  Nature       Date:  1971-07-02       Impact factor: 49.962

5.  A system of immunofluorescence in the study of tumour cells.

Authors:  T M Phillips; M G Lewis
Journal:  Rev Eur Etud Clin Biol       Date:  1970-11

6.  Delayed hypersensitivity and transplantation immunity elicited by soluble antigens of chemically induced tumours in inbred guinea-pigs.

Authors:  H F Oettgen; L J Old; E P McLean; E A Carswell
Journal:  Nature       Date:  1968-10-19       Impact factor: 49.962

7.  Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease.

Authors:  M G Lewis; R L Ikonopisov; R C Nairn; T M Phillips; G H Fairley; D C Bodenham; P Alexander
Journal:  Br Med J       Date:  1969-09-06

8.  Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma.

Authors:  G A Currie; F Lejeune; G H Fairley
Journal:  Br Med J       Date:  1971-05-08

9.  Some aspects of the immune defense against cancer. I. In vitro studies on animal tumors.

Authors:  K E Hellström; I Hellström
Journal:  Cancer       Date:  1971-11       Impact factor: 6.860

10.  Malignant melanoma in Uganda. (The relationship between pigmentation and malignant melanoma on the soles of the feet).

Authors:  M G Lewis
Journal:  Br J Cancer       Date:  1967-09       Impact factor: 7.640
View more
  7 in total

1.  Soluble proteins and hydrolases during crown-gall induction in the tomato, Lycopersicon esculentum.

Authors:  K M Sheikh; P B Gahan
Journal:  Histochem J       Date:  1976-01

2.  [Carcinofetal antigens. III. Further carcinofetal antigens (author's transl)].

Authors:  R Lamerz; A Fateh-Moghadam
Journal:  Klin Wochenschr       Date:  1975-05-01

3.  Evaluation of the humoral response of meningioma patients to possible common tumour-associated antigens.

Authors:  S Mottet; A Martin-Achard; N de Tribolet; A C Diserens
Journal:  Acta Neurochir (Wien)       Date:  1980       Impact factor: 2.216

4.  Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.

Authors:  H H Peter; J R Kalden; P Seeland; V Diehl; G Eckert
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

5.  Anti-poly(A) polymerase antibodies in sera of tumor-bearing rats and human cancer patients.

Authors:  D A Stetler; K M Rose; S T Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

6.  Cellular localization of immunoglobulin within human maglignant melanomata.

Authors:  M G Lewis; J W Proctor; D M Thomson; G Rowden; T M Phillips
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

Review 7.  Applications of SNAP-tag technology in skin cancer therapy.

Authors:  Eden Rebecca Padayachee; Henry Ademola Adeola; Jennifer Catherine Van Wyk; Fleury Augustine Nsole Biteghe; Shivan Chetty; Nonhlanhla Patience Khumalo; Stefan Barth
Journal:  Health Sci Rep       Date:  2019-01-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.